Clinical Trials
8 trialsNCT05600322 2024-10-03
Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer
Photocure
Phase 3 Completed
NCT03058705 2019-08-19
Near Infrared Fluorescence Imaging for Bladder Cancer Detection
University of Rochester
Phase NA Completed
NCT02560584 2018-07-02
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
Photocure
Phase 3 Completed
NCT02149342 2016-07-11
Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL
Joint Authority for Päijät-Häme Social and Health Care
Phase 1/2 Completed
NCT00634621 2014-08-25
Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer
GE Healthcare
Completed
NCT00233402 2013-10-11
Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
Photocure
Phase 3 Completed
NCT00412971 2013-10-11
A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer
Photocure
Phase 3 Completed
NCT00708942 2013-04-24
Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
Photocure
Phase 2 Terminated